The maker of Scotch tape is joining the AI hype party...

3M (MMM) is a familiar name. It makes the tape you use to wrap a birthday present... and the adhesive strips you use to hang a picture on the wall.

But 3M is much more than that...

The company produces more than 60,000 products across industrial, consumer, healthcare, technology, and transportation sectors.

3M can help you fly across the country, paint your car, or get crowns on your teeth.

And with its deep bench of inventions, it has a history of taking advantage of fresh opportunities...

For example, when the COVID-19 pandemic struck, 3M suddenly had huge demand for N95 face masks – which it had invented in 1972.

Now, with billions of dollars pouring into AI data centers, 3M is rushing to meet demand for another innocuous-sounding product.

Earlier this month, 3M announced it would provide its expanded beam optical ("EBO") fiber-optic connectors for Microsoft's (MSFT) data centers.

As the company explained in its press release:

EBO technology is designed to make fiber connections faster to install, more tolerant of contamination and easier to maintain. The technology will help Microsoft reduce the need for frequent cleaning and inspection while supporting reliable optical performance in dense, high-volume deployment environments.

3M CEO Bill Brown believes EBO could bring in another $40 million to $50 million in revenue this year. That may not sound like a lot for a huge business like 3M... But he sees demand surging fivefold within the next few years.

Lots of people are throwing their money into AI investments these days... And most of them are chasing all the same overhyped, overvalued names like Nvidia (NVDA) and SpaceX (SPCX).

As I wrote last week, SpaceX jumped after its recent IPO, but quickly fell well below that price. And Nvidia's stock kept seeing the monster gains it enjoyed at the beginning of the AI boom.

Most of the folks who made big gains on SpaceX and Nvidia were early investors. They got in ahead of the crowd. Those who joined later took on big risks for much lower gains... at best. In SpaceX's case, they're probably going to lose a lot of money.

So if you're itching to invest in AI, I recommend looking beyond the obvious plays.

3M is making money from AI, thanks to its new EBO technology... But it's also a great business with plenty of other revenue drivers.

AI can help 3M's returns, but the company won't get wiped out if an AI bubble bursts.

This is the sort of AI bet that I could get behind.

My colleague Luke Lango is also on the hunt for overlooked AI winners...

Luke, from our corporate affiliate InvestorPlace, discussed his strategy in yesterday's 2026 AI Megadeal event. And he explained how one little-known trend could shape the next phase of AI investing.

If you missed Luke's live event yesterday, you can watch a free replay right here.

Now, let's get to this week's Q&A... And as always, keep sending your comments, questions, and topic suggestions to feedback@healthandwealthbulletin.com. My team and I read every e-mail.

Hybrid Batteries Are Nothing to Worry About

Q: One of my relatives bought a used hybrid car a few years ago and the battery failed soon thereafter. Replacing the battery would cost more than the book value of the car, and it wouldn't run without a good battery. Which of the late model SUV hybrids can run as a straight conventional drive train if the battery fails? What age/mileage can one expect from recent model year hybrid batteries? – D.B.

A: I'll turn this question over to the auto expert on my team, Brady Holt...

In hybrid cars, electric motors work together with a gasoline engine to power the vehicle to save gas. If either part of that system fails, the car will stop working. It needs the full hybrid system to run.

Here's the good news...

First, hybrid batteries don't fail often. The technology has proved itself well in more than 25 years on American roads.

Federal law requires a minimum warranty coverage of eight years or 100,000 miles from new. California and some other states require 10 years or 150,000 miles for hybrid batteries. And some automakers include that higher coverage nationwide... notably Toyota, which sells more hybrids in America than anyone else.

It's not really possible to predict whether new hybrids – or any other new cars – will last a long time. The best we can do is look at older cars. And many 20-year-old hybrids are still on the road with more than 200,000 miles on them.

Second, you're right that replacing a hybrid battery can be expensive. But that's no different from replacing a nonhybrid car's engine or transmission. All typically cost thousands of dollars.

Here's another similarity: As with an engine or transmission, price quotes for hybrid batteries will vary a lot. It'll generally cost more if you go to a dealership than an independent shop. You can also often find reconditioned batteries, batteries salvaged from wrecked cars, and even batteries from third-party suppliers.

Here's how I'd look at it... Any older car can get a repair estimate that exceeds the car's value. That's especially true if you take the car to a dealer.

None of that is a reason to avoid a hybrid. If you're interested in small SUVs, I'm a big fan of the Honda CR-V, Toyota RAV4 and Corolla Cross, Hyundai Tucson, and Kia Sportage hybrids. They have lots of room and can get more than 40 mpg.

What We're Reading...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
July 31, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top